PC
JUNO

Pier Capital’s Juno Therapeutics, Inc. JUNO Stock Holding History

Pier Capital’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-126,177
Closed -$5.77M – 132
2017
Q4 		$5.77M Buy
126,177
+3,188
+3% +$159K 0.99% 55
2017
Q3 		$5.52M Buy
+122,989
New +$4.19M 0.96% 68

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Pier Capital's JUNO Position: Q1 2018 in Review

Pier Capital sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 126,177 shares — an estimated $5.77M sold.

Pier Capital first reported a position in JUNO in Q3 2017 and held it in 2 quarters. The position peaked at $5.77M in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • Pier Capital reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Pier Capital sold 126,177 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $5.77M.
  • Pier Capital first reported a position in Juno Therapeutics, Inc. in Q3 2017 and held it in 2 quarters.
  • Pier Capital's Juno Therapeutics, Inc. position peaked at $5.77M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Pier Capital's 13F filing for Q1 2018, filed 14 May 2018.